Internal Medicine, Pulmonary Disease · Houston, TX
NPI
1992012173
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6445 Main Street, Opc 26-100
Houston, TX, 77030
Phone (713) 441-5451
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
1,066 services
Medicare patients, 2024
183
Average age 67
Drug cost, 2024
$1.9M
2,248 prescriptions
Company payments, 2025
$1,913
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad Goodarzi was code 99233 (hospital e&m - subsequent), 393 times for 70 patients. In total Ahmad Goodarzi billed 1,066 services in 41 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 393 | 70 | $92.74 | $36K |
| 31645 Bronchoscopy | Facility | 158 | 75 | $63.15 | $9,978 |
| 99215 Office E&M - Established | Facility | 152 | 112 | $104.12 | $16K |
| 99291 Critical Care E&M | Facility | 107 | 24 | $167.95 | $18K |
| 31628 Bronchoscopy | Facility | 75 | 52 | $119.49 | $8,962 |
| 99223 Hospital E&M - Initial | Facility | 39 | 36 | $124.39 | $4,851 |
| 31632 Bronchoscopy | Facility | 33 | 27 | $36.08 | $1,191 |
By year: 2022 $148K for 1,523 services; 2023 $118K for 1,212 services; 2024 $106K for 1,066 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad Goodarzi prescribed most often to Medicare patients was Prednisone, with 193 prescriptions and refills. In total Ahmad Goodarzi wrote 2,248 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 193 | 396 | 84 | $1,371 |
| Azithromycin Generic | 163 | 340 | 59 | $3,028 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 132 | 278 | 54 | $962 |
| Pantoprazole Sodium Generic | 115 | 265 | 42 | $1,623 |
| Tacrolimus Generic | 99 | 174 | 34 | $8,895 |
| Valganciclovir Hcl Generic | 67 | 143 | 26 | $47K |
| Metoprolol Tartrate Generic | 66 | 145 | 30 | $398 |
| Montelukast Sodium Generic | 60 | 126 | 28 | $785 |
| Atovaquone Generic | 55 | 86 | 14 | $47K |
| Rosuvastatin Calcium Generic | 50 | 127 | 23 | $878 |
| Pravastatin Sodium Generic | 46 | 125 | 18 | $489 |
| Mycophenolic Acid Mycophenolate Sodium | 45 | 77 | 16 | $8,611 |
| Gabapentin Generic | 42 | 80 | 18 | $858 |
| Eliquis Apixaban | 39 | 50 | 14 | $27K |
| Furosemide Generic | 38 | 46 | 17 | $79.99 |
Brand drugs: - claims; generic drugs: 1,894 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad Goodarzi $1,913 ($1,913 in general payments such as food, travel and fees) from 18 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 11 | $296 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $258 |
| Insmed, Inc. INSM | 13 | $234 |
| United Therapeutics Corporation UTHR | 11 | $208 |
| Astellas Pharma US Inc 4503.T | 5 | $190 |
| Grifols USA, LLC | 4 | $103 |
| GlaxoSmithKline, LLC. GSK | 4 | $98.31 |
| Viatris Specialty LLC | 3 | $97.55 |
| Shionogi Inc 4507.T | 4 | $86.75 |
| Baxter Healthcare BAX | 3 | $67.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.